Ribosomes from an Oxazolidinone-Resistant Mutant Confer Resistance to Eperezolid in a Staphylococcus aureus Cell-Free Transcription-Translation Assay
- 1 April 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (4), 947-950
- https://doi.org/10.1128/aac.42.4.947
Abstract
Oxazolidinone-resistant mutants of Staphylococcus aureus , isolated with a spiral plating technique, had a 16-fold higher MIC (2 versus 32 μg/ml) of eperezolid when compared to the parental sensitive strain. Eperezolid inhibited in vitro protein translation with 50% inhibitory concentrations of 30 μM for the oxazolidinone-sensitive S30 extract and 75 μM for the resistant extract. Experiments mixing various combinations of S100 and crude ribosome preparations from oxazolidinone-sensitive and -resistant S. aureus strains in a transcription-translation assay demonstrated that the resistant determinant resided within the ribosomal fraction. Ribosomes from the oxazolidinone-resistant strain bound less drug than ribosomes from the sensitive strain, indicating that the ribosome is the site of action for the oxazolidinones. These experiments demonstrate that an alteration of the ribosome is responsible for some or all of the oxazolidinone resistance observed in the S. aureus mutant.Keywords
This publication has 22 references indexed in Scilit:
- Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial ActivityJournal of Medicinal Chemistry, 1996
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996
- Antibacterial oxazolidinones: In vitro activity of a new analogue, E3709Diagnostic Microbiology and Infectious Disease, 1992
- An in vitro coupled transcription-translation system from Staphylococcus aureusGene, 1991
- RIBOSOMAL RNA AND TRANSLATIONAnnual Review of Biochemistry, 1991
- Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against Staphylococci and StreptococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988
- The mechanism of action of DuP 721, a new antibacterial agent: Effects on macromolecular synthesisBiochemical and Biophysical Research Communications, 1988
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Interaction between Guanosine Derivatives and Factors involved in the Initiation of Protein SynthesisNature, 1970